Cas:17653-93-9 2-(3-methoxyphenyl)-2-methylpropanenitrile manufacturer & supplier

We serve Chemical Name:2-(3-methoxyphenyl)-2-methylpropanenitrile CAS:17653-93-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-(3-methoxyphenyl)-2-methylpropanenitrile

Chemical Name:2-(3-methoxyphenyl)-2-methylpropanenitrile
CAS.NO:17653-93-9
Synonyms:2-(3-methoxy-phenyl)-2-methyl-propionitrile;2-(2-ACETYL THYDRAZINA)-7-CHLORO-5-PHENYL-3H-1,4-BENZODIAZAPINE;2-(3-Methoxyphenyl)-2-methylpropionitril;Benzeneacetonitrile,3-methoxy-a,a-dimethyl
Molecular Formula:C11H13NO
Molecular Weight:175.22700
HS Code:2926909090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:33.02000
Exact Mass:175.10000
LogP:2.49638

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-(3-methoxy-phenyl)-2-methyl-propionitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzeneacetonitrile,3-methoxy-a,a-dimethyl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(2-ACETYL THYDRAZINA)-7-CHLORO-5-PHENYL-3H-1,4-BENZODIAZAPINE Use and application,2-(3-Methoxyphenyl)-2-methylpropionitril technical grade,usp/ep/jp grade.


Related News: The latest outbreak comes as China grapples with an African swine fever epidemic that has infected tens of thousands of pigs. It could stoke more worries among its people about the country��s food supply. 2-(3-methoxyphenyl)-2-methylpropanenitrile manufacturer In 2004, the National Development and Reform Commission, the former Ministry of Health, and the Ministry of Finance jointly formulated and promulgated the Administrative Measures for the Configuration and Use of Large Medical Equipment. This method uses X-ray electronic computer tomography (CT) devices and medical magnetic resonance imaging equipment, digital subtraction angiography X-ray machines of 800 mA or more as the management products of large-scale medical equipment, Purchase and use need to be reported to the provincial health administrative department for approval before approval. However, in recent years, with the comprehensive coverage of medical insurance, such basic medical facilities are being widely popularized, and the relevant implementation rules have directly linked the number of equipment to the number of doctors. Therefore, as the demand for imaging equipment continues to increase, it will have a greater boosting effect on the upstream contrast agent and its raw material market. 2-(3-methoxyphenyl)-2-methylpropanenitrile supplier The company’s product reserves are rich, with more than one hundred varieties in various categories from intermediates to APIs. At present, the grays and anti-hepatitis C series intermediates are steadily advancing, which will ensure future growth. 2-(3-methoxyphenyl)-2-methylpropanenitrile vendor The company’s product reserves are rich, with more than one hundred varieties in various categories from intermediates to APIs. At present, the grays and anti-hepatitis C series intermediates are steadily advancing, which will ensure future growth. 2-(3-methoxyphenyl)-2-methylpropanenitrile factory In 2004, the National Development and Reform Commission, the former Ministry of Health, and the Ministry of Finance jointly formulated and promulgated the Administrative Measures for the Configuration and Use of Large Medical Equipment. This method uses X-ray electronic computer tomography (CT) devices and medical magnetic resonance imaging equipment, digital subtraction angiography X-ray machines of 800 mA or more as the management products of large-scale medical equipment, Purchase and use need to be reported to the provincial health administrative department for approval before approval. However, in recent years, with the comprehensive coverage of medical insurance, such basic medical facilities are being widely popularized, and the relevant implementation rules have directly linked the number of equipment to the number of doctors. Therefore, as the demand for imaging equipment continues to increase, it will have a greater boosting effect on the upstream contrast agent and its raw material market.